posted
***for those not familiar with this stocks, because of the 'F' at the end and because they did not apply for some filling, we cannot see the volume trade during the day...but average is 14M/day***
Medical Services International Requested to Participate in Major Tuberculosis (TB) Test
Tuesday , June 22, 2004 12:37 ET
EDMONTON, Alberta, Jun 22, 2004 /PRNewswire-FirstCall via COMTEX/ -- Medical Services International Inc. (Pinksheets: MSITF) is pleased to announce that it has been invited to participate in a major Tuberculosis (TB) test. Based on the test results of the VScan TB rapid test kit to date, the Company has been asked by an international health organization if it will participate in a large scale TB testing program which is to start in late July, 2004. The VScan TB rapid test kit is the only rapid diagnostic test kit being used in the program. Upon the completion of this program the Company will have enough test data to apply for regulatory approval in all jurisdictions.
Tuberculosis (TB) is a highly contagious disease transmitted through the air contaminated with droplets released from the lungs. TB strikes people in their most productive years, ages 15 to 44. Three million people die from TB every year. Early diagnosis will significantly reduce this number. There is no rapid test kit for TB that has better statistical diagnostic results than VScan TB.
About VScan
The VScan rapid test kit is a single use, easy to use, test for screening of HIV 1&2 and subgroup O, Hepatitis B&C, Tuberculosis (TB), Dengue Fever and West Nile. The kits cannot be used in Canada.
Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or Bill Whitehead Jr. at (416) 822 5883 or http://www.medicalservicesintl.com .
NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies.
SOURCE Medical Services International Inc.
CONTACT: Robert Talbot, +1-780-430-6363, or Bill Whitehead Jr., +1-416-822-5883, both of Medical Services International Inc.
Yes this is good news for them. Been with them for a few months now buying every so often on its way down. Really am ready and waiting for a run Which personally I believe will happen with their entry into the European and Asian markets.
Do you know how the process is going for FDA approval in the US?
braggtd
posted
Medical Services Receives Invitation to Attend Meetings in China via COMTEX
July 13, 2004
EDMONTON, Alberta, Jul 13, 2004 /PRNewswire-FirstCall via COMTEX/ --
Medical Services International Inc. (Pinksheets: MSITF) is pleased to announce that it has received an official invitation from officials in China to attend meetings in July related to the opening of the Shanghai assembly facility. The Shanghai facility was built in anticipation of the approval of the VScan HIV rapid test kit in China. This facility will initially have the ability to produce up to 4,000,000 VScan test kits per year with the capability to be expanded to 8,000,000 VScan test kits per year. The Company currently has confirmed orders in China for 1,400,000 VScan test kits
Medical Services has also agreed with officials in China to immediately ship additional VScan TB rapid test kits to be used for further testing related to the approval of this test kit. China currently does not have set standards related to TB testing. The results obtained by the VScan TB test kit in China have been so good that it is expected that these results will be used to set the standard for TB testing in China. It is reasonable to expect that TB testing in China will exceed 2,000,000 kits per year. There is no other TB test kit available that compares to the independent test results obtained by the VScan TB test kit.
About VScan
The VScan rapid test kit is a single use, easy to use, test for the screening of the HIV 1&2 subgroup O, Hepatitis B&C, Tuberculosis (TB), Dengue Fever and West Nile. The kits cannot be sold in Canada.
Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF." For further information, please contact Robert Talbot at (780) 430 6363 or Bill Whitehead Jr. at (416) 822 5883 or http://www.medicalservicesintl.com .
NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies.
SOURCE Medical Services International Inc.
Robert Talbot, +1-780-430-6363, or Bill Whitehead Jr., +1-416-822-5883, both for Medical Services International http://www.medicalservicesintl.com
Copyright (C) 2004 PR Newswire. All rights reserved.
Bigrod40
posted
Is there a reason this dropped 47% on Friday??
Prdponce
posted
Medical Services to Begin Testing of the VScan TB Test Kit in the United States Wednesday July 14, 6:01 am ET
EDMONTON, Alberta, July 14 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pinksheets: MSITF - News) is pleased to announce that the Company will begin testing of the VScan Tuberculosis (TB) in the United States. The excellent independent test results obtained to date through the testing of the VScan TB test kit and the interest that these test results have generated has resulted in the decision of the Company to immediately begin testing protocols that will allow the Company to submit the TB test kit for regulatory approval in the United States.
ADVERTISEMENT
Tuberculosis is the most infectious disease currently prevalent throughout the world. According to the World Health Organization, Tuberculosis will kill over 8 million people this year. Testing currently available is inaccurate resulting in a large percentage of false positives. False positives result in further expensive and time consuming testing. In remote areas, individuals often do not come back for further testing resulting in situations where the TB virus is being actively spread infecting entire families. The VScan TB test kit gives no false positives (100% Specificity) and during independent testing has shown an accuracy of over 90%. The results are obtained in 10 minutes so if necessary the individual can immediately receive treatment.
About Vscan
The VScan rapid test kit is a single use, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, and West Nile. The kits cannot be sold in Canada.
Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or Bill Whitehead Jr. at (416) 822 5883 or http://www.medicalservicesintl.com.
NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies.
posted 
Which personally I believe will happen with their entry into the European and Asian markets.